Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Gupta, Santosh
Halabi, Susan
Kemeny, Gabor
Anand, Monika
Nanus, David M.
Giannakakou, Paraskevi
George, Daniel J.
Gregory, Simon
Armstrong, Andrew J.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Durham, NC USA
[4] Sandra & Edward Meyer Canc Ctr, New York, NY USA
[5] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA
[6] Duke Univ, Sch Med, Durham, NC USA
[7] Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
147
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC)
    Ferraldeschi, Roberta
    McDaniel, Andrew
    Krupa, Rachel
    Louw, Jessica
    Tucker, Eric
    Bales, Natalee
    Marrinucci, Dena
    Riisnaes, Ruth
    Mateo, Joaquin
    Dittamore, Ryan
    De Bono, Johann Sebastian
    Tomlins, Scott A.
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [42] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Detection and genomic interrogation of invasive circulating tumor cells (iCTCs) derived from men with metastatic castration resistant prostate cancer (mCRPC).
    Friedlander, Terence W.
    Weinberg, Vivian K.
    Roy, Ritu
    Ngo, Vy
    Dong, Huang
    Doty, Shaun
    Zhao, Qiang
    Premasekharan, Gayatri
    Gilbert, Elizabeth
    Ryan, Charles J.
    Chen, Wen-Tien
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Optimal sequencing of enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa Maria
    Bassi, Sunakshi
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Circulating-free DNA (cfDNA) as biomarker of taxane resistance in metastatic castration-resistant prostate cancer (mCRPC)
    Francini, Edoardo
    Ou, Fang-Shu
    Rhoades, Justin
    Wolfe, Eric G.
    O'Connor, Edward
    Ha, Gavin
    Gregory, Gydush
    Kelleher, Kaitlin
    Bhatt, Rupal Satish
    Balk, Steven P.
    Sweeney, Christopher
    Adalsteinsson, Viktor
    Taplin, Mary-Ellen
    Choudhury, Atish Dipankar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [46] Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Danila, D. C.
    Leversha, M. A.
    Gonzalez-Espinoza, R.
    Anand, A.
    Gu, B.
    Gignac, G. A.
    Larson, S.
    Heller, G.
    Fleisher, M.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [48] BURDEN OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN TURKEY
    Erdal, E.
    Malhan, S.
    Oksuz, E.
    Benekli, M.
    Cag, C.
    Dane, F.
    Kabasakal, L.
    Kucuk, O.
    Sozen, T. S.
    Sar, C.
    Kahveci, B.
    VALUE IN HEALTH, 2016, 19 (07) : A725 - A726
  • [49] Plasma circulating tumor DNA (ctDNA) based clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)
    Kohli, Manish
    Tan, Winston
    Zheng, Tiantian
    Wang, Amy
    Huo, Yelia
    Montesinos, Carlos
    Wong, Calvin
    Du, Pan
    Jia, Shidong
    Yu, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [50] Testosterone levels in metastatic castration-resistant prostate cancer (mCRPC).
    von Klot, Christoph A. J.
    Boeker, Alena
    Herrmann, Thomas R. W.
    Kramer, Mario W.
    Kuczyk, Markus A.
    Merseburger, Axel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345